Sensing of interleukin-1 cytokines during Streptococcus pneumoniae colonization contributes to macrophage recruitment and bacterial clearance

Infection and Immunity

Volumn 83, Issue 8, 2015, Pages 3204-3212

  Lemon, Jamie K ^a   Miller, Megan R ^a   Weiser, Jeffrey N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 7; RECOMBINANT INTERLEUKIN 7; IL1R1 PROTEIN, MOUSE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL INFECTION; BACTERIAL LOAD; CITROBACTER RODENTIUM; COLON; CONTROLLED STUDY; IMMUNITY; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; INTESTINE INJURY; LYMPHOID TISSUE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; WEIGHT REDUCTION; ANIMAL; C57BL MOUSE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; MICROBIOLOGY; PERITONEUM MACROPHAGE; PNEUMOCOCCAL INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-1BETA; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PNEUMOCOCCAL INFECTIONS; RECEPTORS, INTERLEUKIN-1 TYPE I; STREPTOCOCCUS PNEUMONIAE;

EID: 84937810661     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00224-15     Document Type: Article

References (54)

1. World Health Organization. 2007. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec 82:93-104.
2. Bogaert D, de Groot R, Hermans PWM. 2004. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 4:144-154. http://dx.doi.org/10.1016/S1473-3099(04)00938-7.
3. Siegel SJ, Roche AM, Weiser JN. 2014. Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source. Cell Host Microbe 16:55-67. http://dx.doi.org/10.1016/j.chom.2014.06.005.
4. Short KR, Reading PC, Wang N, Diavatopoulos DA, Wijburg OL. 2012. Increased nasopharyngeal bacterial titers and local inflammation facilitate transmission of Streptococcus pneumoniae. mBio 3(5):e00255-12. http://dx.doi.org/10.1128/mBio.00255-12.
5. Rodrigues F, Foster D, Nicoli E, Trotter C, Vipond B, Muir P, Gonçalves G, Januário L, Finn A. 2013. Relationships between rhinitis symptoms, respiratory viral infections and nasopharyngeal colonization with Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in children attending daycare. Pediatr Infect Dis J 32:227-232. http://dx.doi.org/10.1097/INF.0b013e31827687fc.
6. McCool T, Cate T, Moy G, Weiser J. 2002. The immune response to pneumococcal proteins during experimental human carriage. J Exp Med 195:359-365. http://dx.doi.org/10.1084/jem.20011576.
7. McCool TL, Weiser JN. 2004. Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization. Infect Immun 72:5807-5813. http://dx.doi.org/10.1128/IAI.72.10.5807-5813.2004.
8. Zhang Z, Clarke TB, Weiser JN. 2009. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 119:1899-1909. http://dx.doi.org/10.1172/JCI36731.
9. Davis KM, Nakamura S, Weiser JN. 2011. Nod2 sensing of lysozymedigested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J Clin Invest 121:3666-3676. http://dx.doi.org/10.1172/JCI57761.
10. Tanabe T, Chamaillard M, Ogura Y, Zhu L, Qiu S, Masumoto J, Ghosh P, Moran A, Predergast MM, Tromp G, Williams CJ, Inohara N, Núñez G. 2004. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J 23:1587-1597. http://dx.doi.org/10.1038/sj.emboj.7600175.
11. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278:8869-8872. http://dx.doi.org/10.1074/jbc.C200651200.
12. Lemon JK, Weiser JN. 2015. Degradation products of the extracellular pathogen Streptococcus pneumoniae access the cytosol via its pore-forming toxin. mBio 6(1):e02110-14. http://dx.doi.org/10.1128/mBio.02110-14.
13. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. 2001. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 276:4812-4818. http://dx.doi.org/10.1074/jbc.M008072200.
14. Cookson BT, Brennan MA. 2001. Pro-inflammatory programmed cell death. Trends Microbiol 9:113-114. http://dx.doi.org/10.1016/S0966-842X(00)01936-3.
15. Fang R, Tsuchiya K, Kawamura I, Shen Y, Hara H, Sakai S, Yamamoto T, Fernandes-Alnemri T, Yang R, Hernandez-Cuellar E, Dewamitta SR, Xu Y, Qu H, Alnemri ES, Mitsuyama M. 2011. Critical roles of ASC inflammasomes in caspase-1 activation and host innate resistance to Streptococcus pneumoniae infection. J Immunol 187:4890-4899. http://dx.doi.org/10.4049/jimmunol.1100381.
16. McNeela EA, Burke Á, Neill DR, Baxter C, Fernandes VE, Ferreira D, Smeaton S, El-Rachkidy R, McLoughlin RM, Mori A, Moran B, Fitzgerald KA, Tschopp J, Pétrilli V, Andrew PW, Kadioglu A, Lavelle EC. 2010. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog 6:e1001191.
17. Karmakar M, Katsnelson M, Malak HA, Greene NG, Howell SJ, Hise AG, Camilli A, Kadioglu A, Dubyak GR, Pearlman E. 2015. Neutrophil IL-1β processing induced by pneumolysin is mediated by the NLRP3/ASC inflammasome and caspase-1 activation and is dependent on K+ efflux. J Immunol 194:1763-1775. http://dx.doi.org/10.4049/jimmunol.1401624.
18. Kafka D, Ling E, Feldman G, Benharroch D, Voronov E, Givon-Lavi N, Iwakura Y, Dagan R, Apte RN, Mizrachi-Nebenzahl Y. 2008. Contribution of IL-1 to resistance to Streptococcus pneumoniae infection. Int Immunol 20:1139-1146. http://dx.doi.org/10.1093/intimm/dxn071.
19. Glaccum MB, Stocking KL, Charrier K, Smith JL, Willis CR, Maliszewski C, Livingston DJ, Peschon JJ, Morrissey PJ. 1997. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J Immunol 159:3364-3371.
20. Ratner AJ, Aguilar JL, Shchepetov M, Lysenko ES, Weiser JN. 2007. Nod1 mediates cytoplasmic sensing of combinations of extracellular bacteria. Cell Microbiol 9:1343-1351. http://dx.doi.org/10.1111/j.1462-5822.2006.00878.x.
21. Sung C, Li H, Claverys J, Morrison D. 2001. An rpsL cassette, Janus, for gene replacement through negative selection in Streptococcus pneumoniae. Appl Environ Microbiol 67:5190-5196. http://dx.doi.org/10.1128/AEM.67.11.5190-5196.2001.
22. DeBardeleben HK, Lysenko ES, Dalia AB, Weiser JN. 2014. Tolerance of a phage element by Streptococcus pneumoniae leads to a fitness defect during colonization. J Bacteriol 196:2670-2680. http://dx.doi.org/10.1128/JB.01556-14.
23. Bauernfeind F, Bartok E, Rieger A, Franchi L, Núñez G, Hornung V. 2011. Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J Immunol 187:613-617. http://dx.doi.org/10.4049/jimmunol.1100613.
24. Bulua AC, Simon A, Maddipati R, Pelletier M, Park H, Kim K-Y, Sack MN, Kastner DL, Siegel RM. 2011. Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J Exp Med 208:519-533. http://dx.doi.org/10.1084/jem.20102049.
25. Kahlenberg JM, Lundberg KC, Kertesy SB, Qu Y, Dubyak GR. 2005. Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-kappaB-driven protein synthesis. J Immunol 175:7611-7622. http://dx.doi.org/10.4049/jimmunol.175.11.7611.
26. Witzenrath M, Pache F, Lorenz D, Koppe U, Gutbier B, Tabeling C, Reppe K, Meixenberger K, Dorhoi A, Ma J, Holmes A, Trendelenburg G, Heimesaat MM, Bereswill S, van der Linden M, Tschopp J, Mitchell TJ, Suttorp N, Opitz B. 2011. The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia. J Immunol 187:434-440. http://dx.doi.org/10.4049/jimmunol.1003143.
27. van Rossum AMC, Lysenko ES, Weiser JN. 2005. Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model. Infect Immun 73:7718-7726. http://dx.doi.org/10.1128/IAI.73.11.7718-7726.2005.
28. Matsukawa A, Lukacs NW, Hogaboam CM, Chensue SW, Kunkel SL. 2001. Chemokines and other mediators. 8. Chemokines and their receptors in cell-mediated immune responses in the lung. Microsc Res Tech 53:298-306.
29. Malley R, Stack AM, Ferretti ML, Thompson CM, Saladino RA. 1998. Anticapsular polysaccharide antibodies and nasopharyngeal colonization with Streptococcus pneumoniae in infant rats. J Infect Dis 178:878-882. http://dx.doi.org/10.1086/597600.
30. Dagan R, Melamed R, Muallem M, Piglansky L, Greenberg D, Abramson O, Mendelman PM, Bohidar N, Yagupsky P. 1996. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis 174:1271-1278. http://dx.doi.org/10.1093/infdis/174.6.1271.
31. Lu Y-J, Gross J, Bogaert D, Finn A, Bagrade L, Zhang Q, Kolls JK, Srivastava A, Lundgren A, Forte S, Thompson CM, Harney KF, Anderson PW, Lipsitch M, Malley R. 2008. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 4:e1000159.
32. Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, Kang HS, Ma L, Watowich SS, Jetten AM, Tian Q, Dong C. 2009. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30:576-587. http://dx.doi.org/10.1016/j.immuni.2009.02.007.
33. Neill DR, Coward WR, Gritzfeld JF, Richards L, Garcia-Garcia FJ, Dotor J, Gordon SB, Kadioglu A. 2014. Density and duration of pneumococcal carriage is maintained by transforming growth factor β1 and T regulatory cells. Am J Respir Crit Care Med 189:1250-1259. http://dx.doi.org/10.1164/rccm.201401-0128OC.
34. Hultgren OH, Svensson L, Tarkowski A. 2002. Critical role of signaling through IL-1 receptor for development of arthritis and sepsis during Staphylococcus aureus infection. J Immunol 168:5207-5212. http://dx.doi.org/10.4049/jimmunol.168.10.5207.
35. Biondo C, Mancuso G, Midiri A, Signorino G, Domina M, Lanza Cariccio V, Venza M, Venza I, Teti G, Beninati C. 2014. Essential role of interleukin-1 signaling in host defenses against group B Streptococcus. mBio 5(5):e01428-14. http://dx.doi.org/10.1128/mBio.01428-14.
36. Gupta R, Ghosh S, Monks B, Deoliveira R, Tzeng T, Kalantari P, Nandy A, Bhattacharjee B, Chan J, Ferreira F, Rathinam V, Sharma S, Lien E, Silverman N, Fitzgerald K, Firon A, Trieu-Cuot P, Henneke P, Golenbock D. 2014. RNA and βhemolysin of group B Streptococcus induce IL-1β by activating NLRP3 inflammasomes in mouse macrophages. J Biol Chem 289:13701-13705. http://dx.doi.org/10.1074/jbc.C114.548982.
37. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228-232. http://dx.doi.org/10.1038/nature04515.
38. Biondo C, Mancuso G, Midiri A, Signorino G, Domina M, Lanza Cariccio V, Mohammadi N, Venza M, Venza I, Teti G, Beninati C. 2014. The interleukin-1β/CXCL1/2/neutrophil axis mediates host protection against group B streptococcal infection. Infect Immun 82:4508-4517. http://dx.doi.org/10.1128/IAI.02104-14.
39. Mölne L, Verdrengh M, Tarkowski A. 2000. Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus. Infect Immun 68:6162-6167. http://dx.doi.org/10.1128/IAI.68.11.6162-6167.2000.
40. Caffrey AK, Lehmann MM, Zickovich JM, Espinosa V, Shepardson KM, Watschke CP, Hilmer KM, Thammahong A, Barker BM, Rivera A, Cramer RA, Obar JJ. 2015. IL-1 signaling is critical for leukocyte recruitment after pulmonary Aspergillus fumigatus challenge. PLoS Pathog 11:e1004625.
41. Orlofsky A, Berger MS, Prystowsky MB. 1991. Novel expression pattern of a new member of the MIP-1 family of cytokine-like genes. Cell Regul 2:403-412.
42. LaFleur AM, Lukacs NW, Kunkel SL, Matsukawa A. 2004. Role of CC chemokine CCL6/C10 as a monocyte chemoattractant in a murine acute peritonitis. Mediators Inflamm 13:349-355. http://dx.doi.org/10.1080/09629350400014172.
43. Wu Y, Prystowsky MB, Orlofsky A. 1999. Sustained high-level production of murine chemokine C10 during chronic inflammation. Cytokine 11:523-530. http://dx.doi.org/10.1006/cyto.1998.0436.
44. Kanno M, Suzuki S, Fujiwara T, Yokoyama A, Sakamoto A, Takahashi H, Imai Y, Tanaka J. 2005. Functional expression of CCL6 by rat microglia:a possible role of CCL6 in cell-cell communication. J Neuroimmunol 167:72-80. http://dx.doi.org/10.1016/j.jneuroim.2005.06.028.
45. Hogaboam CM, Chensue SW, Steinhauser ML, Huffnagle GB, Lukacs NW, Strieter RM, Kunkel SL. 1997. Alteration of the cytokine phenotype in an experimental lung granuloma model by inhibiting nitric oxide. J Immunol 159:5585-5593.
46. Kotarsky K, Sitnik KM, Stenstad H, Kotarsky H, Schmidtchen A, Koslowski M, Wehkamp J, Agace WW. 2010. A novel role for constitutively expressed epithelial-derived chemokines as antibacterial peptides in the intestinal mucosa. Mucosal Immunol 3:40-48. http://dx.doi.org/10.1038/mi.2009.115.
47. Coelho AL, Schaller MA, Benjamim CF, Orlofsky AZ, Hogaboam CM, Kunkel SL. 2007. The chemokine CCL6 promotes innate immunity via immune cell activation and recruitment. J Immunol 179:5474-5482. http://dx.doi.org/10.4049/jimmunol.179.8.5474.
48. Orlofsky A, Lin EY, Prystowsky MB. 1994. Selective induction of the beta chemokine C10 by IL-4 in mouse macrophages. J Immunol 152:5084-5091.
49. Conway DH, Dara J, Bagashev A, Sullivan KE. 2010. Myeloid differentiation primary response gene 88 (MyD88) deficiency in a large kindred. J Allergy Clin Immunol 126:172-175. http://dx.doi.org/10.1016/j.jaci.2010.04.014.
50. Picard C, Casanova J-L, Puel A. 2011. Infectious diseases in patients with IRAK-4, MyD88, NEMO, or I kappa B alpha deficiency. Clin Microbiol Rev 24:490-497. http://dx.doi.org/10.1128/CMR.00001-11.
51. von Bernuth H, Picard C, Jin Z, Pankla R, Xiao H, Ku C-L, Chrabieh M, Mustapha IB, Ghandil P, Camcioglu Y, Vasconcelos J, Sirvent N, Guedes M, Vitor AB, Herrero-Mata MJ, Aróstegui JI, Rodrigo C, Alsina L, Ruiz-Ortiz E, Juan M, Fortuny C, Yagüe J, Antón J, Pascal M, Chang H-H, Janniere L, Rose Y, Garty B-Z, Chapel H, Issekutz A, Maródi L, Rodriguez-Gallego C, Banchereau J, Abel L, Li X, Chaussabel D, Puel A, Casanova J-L. 2008. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321:691-696. http://dx.doi.org/10.1126/science.1158298.
52. Ku C-L, von Bernuth H, Picard C, Zhang S-Y, Chang H-H, Yang K, Chrabieh M, Issekutz AC, Cunningham CK, Gallin J, Holland SM, Roifman C, Ehl S, Smart J, Tang M, Barrat FJ, Levy O, McDonald D, Day-Good NK, Miller R, Takada H, Hara T, Al-Hajjar S, Al-Ghonaium A, Speert D, Sanlaville D, Li X, Geissmann F, Vivier E, Maródi L, Garty B-Z, Chapel H, Rodriguez-Gallego C, Bossuyt X, Abel L, Puel A, Casanova J-L. 2007. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med 204:2407-2422. http://dx.doi.org/10.1084/jem.20070628.
53. Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, Yang K, Soudais C, Dupuis S, Feinberg J, Fieschi C, Elbim C, Hitchcock R, Lammas D, Davies G, Al-Ghonaium A, Al-Rayes H, Al-Jumaah S, Al-Hajjar S, Al-Mohsen IZ, Frayha HH, Rucker R, Hawn TR, Aderem A, Tufenkeji H, Haraguchi S, Day NK, Good RA, Gougerot-Pocidalo MA, Ozinsky A, Casanova JL. 2003. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299:2076-2079. http://dx.doi.org/10.1126/science.1081902.
54. Moens L, Verhaegen J, Pierik M, Vermeire S, De Boeck K, Peetermans WE, Bossuyt X. 2007. Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal disease. Microbes Infect 9:15-20. http://dx.doi.org/10.1016/j.micinf.2006.10.002.